SCHEMBL4959356

SCHEMBL4959356

Cc1ccc(S(C)(=O)=O)cc1C(N)=O

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
LMNA P02545 1/20 0.50
TDP1 Q9NUW8 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
IKBKB O14920 1/20 0.44
CHUK O15111 1/20 0.44
CSF1R P07333 1/20 0.42
SIRT3 Q9NTG7 1/20 0.42
BRD4 O60885 1/20 0.41
ADRA1D P25100 2/20 0.41
ENPP2 Q13822 1/20 0.41
G6PD P11413 1/20 0.41
IDE P14735 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28166017 0.85 LMNA (0.46) MAPK1LMNAIKBKBCHUKBRD4
SCHEMBL1805024 0.85 MAPK1 (0.55) MAPK1SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL1805549 0.85 MAPK1 (0.55) MAPK1SMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL15836210 0.83 LMNA (0.51) MAPK1SMN1; SMN2LMNATDP1ENPP2
SCHEMBL35247 0.83 LMNA (0.66) MAPK1LMNATDP1L3MBTL1ENPP2
SCHEMBL7125193 0.82 SLC9A1 (0.63)
SCHEMBL2854356 0.80 LMNA (0.49) LMNAIKBKBCHUKCSF1RBRD4
SCHEMBL7125185 0.79 TDP1 (0.42) MAPK1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL8350642 0.79 LMNA (0.47) SMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL8804424 0.78 TDP1 (0.41) MAPK1SMN1; SMN2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881961-A1 NEW HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES NOVO NORDISK A/S (DK) 2008-01-30 EP claimed
WO-2006120178-A1 NEW HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES NOVO NORDISK A/S (DK) 2006-11-16 WO claimed
WO-2019055590-A1 BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF AMGEN INC. (US) 2019-03-21 WO disclosed
EP-1881961-A1 NEW HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES NOVO NORDISK A/S (DK) 2008-01-30 EP disclosed
WO-2006120178-A1 NEW HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES NOVO NORDISK A/S (DK) 2006-11-16 WO disclosed